Your session is about to expire
← Back to Search
Wound vac application for Lower Extremity Wound
N/A
Waitlist Available
Led By Suhail Mithani, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 2 (day of second operative debridement)
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the amount of infection and the need for more surgery in patients who have surgery to remove infected tissue, abscesses, or traumatic wounds.
Eligible Conditions
- Abscess
- Arm Wound
- Lower Extremity Wound
- Traumatic Wounds
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 2 (day of second operative debridement)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 2 (day of second operative debridement)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Bio-burden as Measured by Qualitative Microbial PCR (Polymerase Chain Reaction) After First Debridement
Bio-burden as Measured by Qualitative Microbial PCR (Polymerase Chain Reaction) Prior to First Debridement
Bio-burden as Measured by Qualitative Microbial PCR (Polymerase Chain Reaction) Prior to Second Debridement
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Wound vac applicationActive Control1 Intervention
Wound vac application for open upper/lower extremity open wound
Group II: Wound vac application including irrigationActive Control1 Intervention
Wound vac application WITH irrigation for upper/lower extremity open wound
Find a Location
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,455 Previous Clinical Trials
2,971,074 Total Patients Enrolled
3MIndustry Sponsor
158 Previous Clinical Trials
31,479 Total Patients Enrolled
Suhail Mithani, MDPrincipal InvestigatorDuke Health System
1 Previous Clinical Trials
Share this study with friends
Copy Link
Messenger